LDL-C goal Attainment Among Patients Newly Diagnosed With Coronary Heart Disease or Diabetes in a Commercial HMO

BACKGROUND: Patients beginning treatment with lipid-modifying drugs should have their serum lipid levels monitored and, if necessary, their drug therapy adjusted to reach and maintain their treatment goals. Patients with coronary heart disease or diabetes are at high risk of coronary events and are...

Descripción completa

Detalles Bibliográficos
Autores principales: Nag, Soma S., Daniel, Gregory W., Bullano, Michael F., Kamal-Bahl, Sachin, Sajjan, Shiva G., Hu, Henry, Alexander, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437400/
https://www.ncbi.nlm.nih.gov/pubmed/17970603
http://dx.doi.org/10.18553/jmcp.2007.13.8.652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437400/
https://www.ncbi.nlm.nih.gov/pubmed/17970603
http://dx.doi.org/10.18553/jmcp.2007.13.8.652

Ejemplares similares